
Sean E. Aeder
Examiner (ID: 2139, Phone: (571)272-8787 , Office: P/1642 )
| Most Active Art Unit | 1642 |
| Art Unit(s) | 1642 |
| Total Applications | 1939 |
| Issued Applications | 907 |
| Pending Applications | 201 |
| Abandoned Applications | 855 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5887676
[patent_doc_number] => 20060275304
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-07
[patent_title] => 'Novel tumor antigen useful in diagnosis and therapy of prostate and colon cancer'
[patent_app_type] => utility
[patent_app_number] => 11/200973
[patent_app_country] => US
[patent_app_date] => 2005-08-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14982
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0275/20060275304.pdf
[firstpage_image] =>[orig_patent_app_number] => 11200973
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/200973 | Novel tumor antigen useful in diagnosis and therapy of prostate and colon cancer | Aug 8, 2005 | Abandoned |
Array
(
[id] => 5827871
[patent_doc_number] => 20060063179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-23
[patent_title] => 'MIFL- a new partner gene of MLL and methods of use thereof'
[patent_app_type] => utility
[patent_app_number] => 11/199544
[patent_app_country] => US
[patent_app_date] => 2005-08-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 17614
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0063/20060063179.pdf
[firstpage_image] =>[orig_patent_app_number] => 11199544
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/199544 | MIFL- a new partner gene of MLL and methods of use thereof | Aug 7, 2005 | Abandoned |
| 11/191273 | Colon disease targets and uses thereof | Jul 27, 2005 | Abandoned |
Array
(
[id] => 5514211
[patent_doc_number] => 20090214517
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-08-27
[patent_title] => 'Compositions and methods of use for modulators of nectin 4, semaphorin 4b, igsf9, and kiaa0152 in treating disease'
[patent_app_type] => utility
[patent_app_number] => 11/658412
[patent_app_country] => US
[patent_app_date] => 2005-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 89
[patent_figures_cnt] => 89
[patent_no_of_words] => 34803
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0214/20090214517.pdf
[firstpage_image] =>[orig_patent_app_number] => 11658412
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/658412 | Compositions and methods of use for modulators of nectin 4, semaphorin 4b, igsf9, and kiaa0152 in treating disease | Jul 26, 2005 | Abandoned |
Array
(
[id] => 5632271
[patent_doc_number] => 20060148741
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-07-06
[patent_title] => 'Metastasis suppressor gene on human chromosome 8 and its use in the diagnosis, prognosis and treatment of cancer'
[patent_app_type] => utility
[patent_app_number] => 11/190027
[patent_app_country] => US
[patent_app_date] => 2005-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10655
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0148/20060148741.pdf
[firstpage_image] =>[orig_patent_app_number] => 11190027
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/190027 | Metastasis suppressor gene on human chromosome 8 and its use in the diagnosis, prognosis and treatment of cancer | Jul 25, 2005 | Abandoned |
Array
(
[id] => 122102
[patent_doc_number] => 07709605
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-05-04
[patent_title] => 'ActRII receptor polypeptides, methods and compositions'
[patent_app_type] => utility
[patent_app_number] => 11/190202
[patent_app_country] => US
[patent_app_date] => 2005-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 17
[patent_no_of_words] => 23157
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/709/07709605.pdf
[firstpage_image] =>[orig_patent_app_number] => 11190202
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/190202 | ActRII receptor polypeptides, methods and compositions | Jul 24, 2005 | Issued |
Array
(
[id] => 5046008
[patent_doc_number] => 20070264681
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2007-11-15
[patent_title] => 'Cell Cycle Phase Markers'
[patent_app_type] => utility
[patent_app_number] => 11/572510
[patent_app_country] => US
[patent_app_date] => 2005-07-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 12758
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0264/20070264681.pdf
[firstpage_image] =>[orig_patent_app_number] => 11572510
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/572510 | Cell cycle phase markers | Jul 21, 2005 | Issued |
Array
(
[id] => 7250337
[patent_doc_number] => 20050272684
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Breast cancer resistance protein (BCRP) and the DNA which encodes it'
[patent_app_type] => utility
[patent_app_number] => 11/184860
[patent_app_country] => US
[patent_app_date] => 2005-07-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 9262
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272684.pdf
[firstpage_image] =>[orig_patent_app_number] => 11184860
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/184860 | Breast cancer resistance protein (BCRP) and the DNA which encodes it | Jul 19, 2005 | Issued |
Array
(
[id] => 5742786
[patent_doc_number] => 20060088511
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-04-27
[patent_title] => 'Cancer therapy sensitizer'
[patent_app_type] => utility
[patent_app_number] => 11/181115
[patent_app_country] => US
[patent_app_date] => 2005-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 198
[patent_figures_cnt] => 198
[patent_no_of_words] => 30980
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11181115
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/181115 | Cancer therapy sensitizer | Jul 13, 2005 | Issued |
Array
(
[id] => 5590841
[patent_doc_number] => 20060040292
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-02-23
[patent_title] => 'Tumor markers and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 11/177894
[patent_app_country] => US
[patent_app_date] => 2005-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 96
[patent_figures_cnt] => 96
[patent_no_of_words] => 14455
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 11
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11177894
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/177894 | Tumor markers and uses thereof | Jul 7, 2005 | Abandoned |
Array
(
[id] => 5710474
[patent_doc_number] => 20060051819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-03-09
[patent_title] => 'Detection, evaluation and treatment for advanced prostate cancer'
[patent_app_type] => utility
[patent_app_number] => 11/156879
[patent_app_country] => US
[patent_app_date] => 2005-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 12651
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0051/20060051819.pdf
[firstpage_image] =>[orig_patent_app_number] => 11156879
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/156879 | Detection, evaluation and treatment for advanced prostate cancer | Jun 16, 2005 | Abandoned |
Array
(
[id] => 8738476
[patent_doc_number] => 08410246
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2013-04-02
[patent_title] => 'TDF-related compounds and analogs thereof'
[patent_app_type] => utility
[patent_app_number] => 11/629558
[patent_app_country] => US
[patent_app_date] => 2005-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 42
[patent_no_of_words] => 86534
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 11629558
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/629558 | TDF-related compounds and analogs thereof | Jun 16, 2005 | Issued |
Array
(
[id] => 909591
[patent_doc_number] => 07329495
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2008-02-12
[patent_title] => 'Mutations in KIT confer imatinib resistance in gastrointestinal stromal tumors'
[patent_app_type] => utility
[patent_app_number] => 11/148770
[patent_app_country] => US
[patent_app_date] => 2005-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 13
[patent_no_of_words] => 28848
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/329/07329495.pdf
[firstpage_image] =>[orig_patent_app_number] => 11148770
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/148770 | Mutations in KIT confer imatinib resistance in gastrointestinal stromal tumors | Jun 8, 2005 | Issued |
Array
(
[id] => 5894824
[patent_doc_number] => 20060003363
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-01-05
[patent_title] => 'GLUT3 transporters expressed in cancer cells'
[patent_app_type] => utility
[patent_app_number] => 11/147110
[patent_app_country] => US
[patent_app_date] => 2005-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 11157
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20060003363.pdf
[firstpage_image] =>[orig_patent_app_number] => 11147110
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/147110 | GLUT3 transporters expressed in cancer cells | Jun 5, 2005 | Abandoned |
Array
(
[id] => 5747815
[patent_doc_number] => 20060110746
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-05-25
[patent_title] => 'Treatment of cancer using TLR3 agonists'
[patent_app_type] => utility
[patent_app_number] => 11/144322
[patent_app_country] => US
[patent_app_date] => 2005-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 19939
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0110/20060110746.pdf
[firstpage_image] =>[orig_patent_app_number] => 11144322
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/144322 | Treatment of cancer using TLR3 agonists | Jun 2, 2005 | Issued |
Array
(
[id] => 5770734
[patent_doc_number] => 20050266530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-01
[patent_title] => 'Cynomolgus prostate specific antigen'
[patent_app_type] => utility
[patent_app_number] => 11/138242
[patent_app_country] => US
[patent_app_date] => 2005-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 5398
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0266/20050266530.pdf
[firstpage_image] =>[orig_patent_app_number] => 11138242
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/138242 | Cynomolgus prostate specific antigen | May 25, 2005 | Issued |
Array
(
[id] => 637883
[patent_doc_number] => 07125836
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2006-10-24
[patent_title] => 'Method of cancer screening; method of cancer treatment; and method of diabetes treatment'
[patent_app_type] => utility
[patent_app_number] => 11/133838
[patent_app_country] => US
[patent_app_date] => 2005-05-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 2491
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/125/07125836.pdf
[firstpage_image] =>[orig_patent_app_number] => 11133838
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/133838 | Method of cancer screening; method of cancer treatment; and method of diabetes treatment | May 18, 2005 | Issued |
Array
(
[id] => 7110610
[patent_doc_number] => 20050208065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-09-22
[patent_title] => 'Immunogenic compositions for induction of anti-tumor immunity'
[patent_app_type] => utility
[patent_app_number] => 11/129359
[patent_app_country] => US
[patent_app_date] => 2005-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8974
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0208/20050208065.pdf
[firstpage_image] =>[orig_patent_app_number] => 11129359
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/129359 | Immunogenic compositions for induction of anti-tumor immunity | May 15, 2005 | Issued |
Array
(
[id] => 7247354
[patent_doc_number] => 20050272102
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2005-12-08
[patent_title] => 'Method for diagnosis of prostate cancer'
[patent_app_type] => utility
[patent_app_number] => 11/127042
[patent_app_country] => US
[patent_app_date] => 2005-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 6931
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0272/20050272102.pdf
[firstpage_image] =>[orig_patent_app_number] => 11127042
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/127042 | Method for diagnosis of prostate cancer | May 10, 2005 | Abandoned |
Array
(
[id] => 5688287
[patent_doc_number] => 20060286602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2006-12-21
[patent_title] => 'Method and markers for the diagnosis of renal diseases'
[patent_app_type] => utility
[patent_app_number] => 11/126385
[patent_app_country] => US
[patent_app_date] => 2005-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 39440
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0286/20060286602.pdf
[firstpage_image] =>[orig_patent_app_number] => 11126385
[rel_patent_id] =>[rel_patent_doc_number] =>) 11/126385 | Method and markers for the diagnosis of renal diseases | May 9, 2005 | Abandoned |